Strategic partnership Adare has recently partnered with Achieve Life Sciences and is actively pursuing collaborations in specialized drug delivery and nicotine dependence therapies, indicating a receptive stance toward co-development and outsourced manufacturing arrangements.

Europe expansion Significant European capacity expansion including Milan facility upgrades and Europe-wide packaging and warehousing improvements create capacity and speed-to-market advantages for partners seeking regional manufacturing and packaging capabilities.

North American footprint Growth in Pennsylvania with headquarters relocation and expansion of Philadelphia facilities signals a strengthened US footprint, enabling closer collaboration with North American customers and faster logistics for small molecule oral dosage programs.

Technology enablement A broad tech stack including analytics and CRM platforms (Power BI, Tableau, Cognos, Salesforce, HubSpot, Dynamics) supports data-driven CDMO operations, enabling partners to monitor development timelines, quality metrics, and supply chain transparency.

Awards and credibility Industry recognition such as the 2025 Outsourced Pharma CDMO Leadership Award enhances market credibility, which can be leveraged in outreach to prospective customers seeking validated small molecule manufacturing and packaging expertise.